1. Home
  2. NEGG vs RCEL Comparison

NEGG vs RCEL Comparison

Compare NEGG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newegg Commerce Inc.

NEGG

Newegg Commerce Inc.

HOLD

Current Price

$35.79

Market Cap

883.1M

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.08

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEGG
RCEL
Founded
2001
N/A
Country
United States
United States
Employees
762
226
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.1M
132.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NEGG
RCEL
Price
$35.79
$4.08
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
32.2K
203.7K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$21.69
Revenue Next Year
N/A
$49.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$3.22
52 Week High
$137.84
$10.28

Technical Indicators

Market Signals
Indicator
NEGG
RCEL
Relative Strength Index (RSI) 33.31 39.94
Support Level $29.87 $3.98
Resistance Level $56.73 $4.09
Average True Range (ATR) 3.37 0.33
MACD -0.58 -0.12
Stochastic Oscillator 36.81 12.96

Price Performance

Historical Comparison
NEGG
RCEL

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: